Literature DB >> 12115603

The anti-apoptotic molecules Bcl-xL and Bcl-w target protein phosphatase 1alpha to Bad.

Verónica Ayllón1, Xavier Cayla, Alphonse García, Aarne Fleischer, Angelita Rebollo.   

Abstract

Bcl-xL and Bcl-w specifically interact with PP1alpha and Bad. A phosphatase activity sensitive to okadaic acid was detected in Bcl-xL, Bcl-w and Bad immunoprecipitates. Serine phosphorylation of Bcl-xL and Bcl-w correlates with the number of trimolecular complexes formed. Depletion of Bcl-xL and Bcl-w decreases the remaining Bad-associated phosphatase activity and association of protein phosphatase 1 (PP1)alpha to Bad. Bcl-xL and Bcl-w contain the R/K X V/I X F consensus motif shared by PP1 targeting subunits. This motif, in addition to F X X R X R motif, is involved in binding of Bcl-xL and Bcl-w to PP1alpha. Disruption of Bcl-xL/PP1alpha or Bcl-w/PP1alpha association strongly decreases Bad-associated phosphataseactivity and stability of trimolecular complexes. These results suggest that Bcl-xL and Bcl-w are PP1alpha targeting subunits and this trimolecular complex may be involved in the control of apoptosis.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12115603     DOI: 10.1002/1521-4141(200207)32:7<1847::AID-IMMU1847>3.0.CO;2-7

Source DB:  PubMed          Journal:  Eur J Immunol        ISSN: 0014-2980            Impact factor:   5.532


  20 in total

1.  Protein phosphatase-1 inhibitor-3 is an in vivo target of caspase-3 and participates in the apoptotic response.

Authors:  Hua-Shan Huang; Ernest Y C Lee
Journal:  J Biol Chem       Date:  2008-05-01       Impact factor: 5.157

2.  Regulation of protein phosphatase 1I by Cdc25C-associated kinase 1 (C-TAK1) and PFTAIRE protein kinase.

Authors:  Jimcy Platholi; Anna Federman; Julia A Detert; Paul Heerdt; Hugh C Hemmings
Journal:  J Biol Chem       Date:  2014-07-15       Impact factor: 5.157

3.  Sequential phosphorylation of smoothened transduces graded hedgehog signaling.

Authors:  Ying Su; Jason K Ospina; Junzheng Zhang; Andrew P Michelson; Adam M Schoen; Alan Jian Zhu
Journal:  Sci Signal       Date:  2011-07-05       Impact factor: 8.192

4.  Protein phosphatase 1γ isoforms linked interactions in the brain.

Authors:  Sara L C Esteves; Luís Korrodi-Gregório; Cândida Z Cotrim; Paula J M van Kleeff; Sara C Domingues; Odete A B da Cruz e Silva; Margarida Fardilha; Edgar F da Cruz e Silva
Journal:  J Mol Neurosci       Date:  2012-10-19       Impact factor: 3.444

5.  Protein phosphatase PP1/GLC7 interaction domain in yeast eIF2γ bypasses targeting subunit requirement for eIF2α dephosphorylation.

Authors:  Margarito Rojas; Anne-Claude Gingras; Thomas E Dever
Journal:  Proc Natl Acad Sci U S A       Date:  2014-03-24       Impact factor: 11.205

6.  Protein phosphatase 1α interacting proteins in the human brain.

Authors:  Sara L C Esteves; Sara C Domingues; Odete A B da Cruz e Silva; Margarida Fardilha; Edgar F da Cruz e Silva
Journal:  OMICS       Date:  2012 Jan-Feb

Review 7.  The impact of phosphatases on proliferative and survival signaling in cancer.

Authors:  Goutham Narla; Jaya Sangodkar; Christopher B Ryder
Journal:  Cell Mol Life Sci       Date:  2018-05-03       Impact factor: 9.261

8.  Activation of brain protein phosphatase-1(I) following cardiac arrest and resuscitation involving an interaction with 14-3-3 gamma.

Authors:  Jimcy Platholi; Paul M Heerdt; H Y Lim Tung; Hugh C Hemmings
Journal:  J Neurochem       Date:  2008-02-14       Impact factor: 5.372

9.  The combinatorial PP1-binding consensus Motif (R/K)x( (0,1))V/IxFxx(R/K)x(R/K) is a new apoptotic signature.

Authors:  Angélique N Godet; Julien Guergnon; Virginie Maire; Amélie Croset; Alphonse Garcia
Journal:  PLoS One       Date:  2010-04-01       Impact factor: 3.240

Review 10.  Signal transduction therapeutics: relevance for Alzheimer's disease.

Authors:  Odete A B da Cruz e Silva; Margarida Fardilha; Ana Gabriela Henriques; Sandra Rebelo; Sandra Vieira; Edgar F da Cruz e Silva
Journal:  J Mol Neurosci       Date:  2004       Impact factor: 3.444

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.